Gemcitabine doublets in advanced pancreatic cancer: should we move on?

MeSH terms

• Antimetabolites, Antineoplastic / administration & dosage
• Antimetabolites, Antineoplastic / adverse effects
• Antimetabolites, Antineoplastic / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Cisplatin / administration & dosage
• Clinical Trials, Phase III as Topic
• Deoxycytidine / administration & dosage
• Deoxycytidine / adverse effects
• Deoxycytidine / analogs & derivatives*
• Deoxycytidine / therapeutic use
• Drug Administration Schedule
• Fluorouracil / therapeutic use
• Gemcitabine
• Humans
• Pancreatic Neoplasms / drug therapy*
• Pancreatic Neoplasms / pathology
• Randomized Controlled Trials as Topic
• Research Design
• Survival Analysis
• Treatment Outcome